
Activist Parvus builds stake in Novo Nordisk
Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk, according to a report from the Financial Times, as the Danish pharmaceutical giant faces increasing investor scrutiny over its positioning in the rapidly evolving weight-loss drug market.
